Skip to main content
. Author manuscript; available in PMC: 2017 Mar 9.
Published in final edited form as: Endocr Pract. 2015 Feb 9;21(6):586–589. doi: 10.4158/EP14412.OR

Table 1.

Patient Characteristics by Treatment Indicationa

CPP Other P value

Total 191 (73.5%) 69 (26.5%)

Gender
 Male 30 (16%) 16 (23%) .16
 Female 161 (84%) 53 (77%)

Age at start of treatment (years) 7.1 ± 2.2 10.7 ± 2.1 <.001

Duration of treatment (years) 3.1 ± 1.9 2.4 ± 1.3 .01

Growth hormone as adjunct 12 (6%) 20 (29%) <.001

Bone age at start of treatment (SDS) 3.2 (2.1) 1 (2.8) <.001

Abbreviations: CPP = central precocious puberty; SDS = standard deviation score.

a

Mean ± SD or n (%).